Vitreous Tamponades

Vitreous Tamponades

Global Vitreous Tamponades Market to Reach $87.1 Million by 2027

In the changed post COVID-19 business landscape, the global market for Vitreous Tamponades estimated at US$71.6 Million in the year 2020, is projected to reach a revised size of US$87.1 Million by 2027, growing at a CAGR of 2.8% over the period 2020-2027. Gaseous Tamponades, one of the segments analyzed in the report, is projected to record 2.7% CAGR and reach US$42 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Liquid Tamponades segment is readjusted to a revised 2.9% CAGR for the next 7-year period.

The U.S. Market is Estimated at $21 Million, While China is Forecast to Grow at 2.7% CAGR

The Vitreous Tamponades market in the U.S. is estimated at US$21 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$15.6 Million by the year 2027 trailing a CAGR of 2.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.6% and 2.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.9% CAGR.

Select Competitors (Total 42 Featured) -

  • AL.CHI.MI.A. Srl
  • Carl Zeiss Meditec AG
  • Dutch Ophthalmic Research Center International BV (D.O.R.C.)
  • Fluron GmbH
  • Novartis AG
  • Valeant Pharmaceuticals International, Inc.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Vitreous Tamponades – Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Vitreous Tamponades by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
TABLE 2: World Historic Review for Vitreous Tamponades by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 3: World 15-Year Perspective for Vitreous Tamponades by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2021 & 2027
TABLE 4: World Recent Past, Current & Future Analysis for Gaseous Tamponades by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
TABLE 5: World Historic Review for Gaseous Tamponades by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 6: World 15-Year Perspective for Gaseous Tamponades by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 7: World Recent Past, Current & Future Analysis for Liquid Tamponades by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
TABLE 8: World Historic Review for Liquid Tamponades by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 9: World 15-Year Perspective for Liquid Tamponades by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 10: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
TABLE 11: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 12: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 13: World Recent Past, Current & Future Analysis for Ophthalmology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
TABLE 14: World Historic Review for Ophthalmology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 15: World 15-Year Perspective for Ophthalmology Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 16: World Vitreous Tamponades Market Analysis of Annual Sales in US$ for Years 2012 through 2027
III. MARKET ANALYSIS
UNITED STATES
Vitreous Tamponades Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
TABLE 17: USA Recent Past, Current & Future Analysis for Vitreous Tamponades by Product - Gaseous Tamponades and Liquid Tamponades - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 18: USA Historic Review for Vitreous Tamponades by Product - Gaseous Tamponades and Liquid Tamponades Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 19: USA 15-Year Perspective for Vitreous Tamponades by Product - Percentage Breakdown of Value Sales for Gaseous Tamponades and Liquid Tamponades for the Years 2012, 2021 & 2027
TABLE 20: USA Recent Past, Current & Future Analysis for Vitreous Tamponades by End-Use - Hospitals and Ophthalmology Clinics - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 21: USA Historic Review for Vitreous Tamponades by End-Use - Hospitals and Ophthalmology Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 22: USA 15-Year Perspective for Vitreous Tamponades by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ophthalmology Clinics for the Years 2012, 2021 & 2027
CANADA
TABLE 23: Canada Recent Past, Current & Future Analysis for Vitreous Tamponades by Product - Gaseous Tamponades and Liquid Tamponades - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 24: Canada Historic Review for Vitreous Tamponades by Product - Gaseous Tamponades and Liquid Tamponades Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 25: Canada 15-Year Perspective for Vitreous Tamponades by Product - Percentage Breakdown of Value Sales for Gaseous Tamponades and Liquid Tamponades for the Years 2012, 2021 & 2027
TABLE 26: Canada Recent Past, Current & Future Analysis for Vitreous Tamponades by End-Use - Hospitals and Ophthalmology Clinics - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 27: Canada Historic Review for Vitreous Tamponades by End-Use - Hospitals and Ophthalmology Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 28: Canada 15-Year Perspective for Vitreous Tamponades by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ophthalmology Clinics for the Years 2012, 2021 & 2027
JAPAN
Vitreous Tamponades Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
TABLE 29: Japan Recent Past, Current & Future Analysis for Vitreous Tamponades by Product - Gaseous Tamponades and Liquid Tamponades - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 30: Japan Historic Review for Vitreous Tamponades by Product - Gaseous Tamponades and Liquid Tamponades Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 31: Japan 15-Year Perspective for Vitreous Tamponades by Product - Percentage Breakdown of Value Sales for Gaseous Tamponades and Liquid Tamponades for the Years 2012, 2021 & 2027
TABLE 32: Japan Recent Past, Current & Future Analysis for Vitreous Tamponades by End-Use - Hospitals and Ophthalmology Clinics - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 33: Japan Historic Review for Vitreous Tamponades by End-Use - Hospitals and Ophthalmology Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 34: Japan 15-Year Perspective for Vitreous Tamponades by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ophthalmology Clinics for the Years 2012, 2021 & 2027
CHINA
Vitreous Tamponades Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
TABLE 35: China Recent Past, Current & Future Analysis for Vitreous Tamponades by Product - Gaseous Tamponades and Liquid Tamponades - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 36: China Historic Review for Vitreous Tamponades by Product - Gaseous Tamponades and Liquid Tamponades Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 37: China 15-Year Perspective for Vitreous Tamponades by Product - Percentage Breakdown of Value Sales for Gaseous Tamponades and Liquid Tamponades for the Years 2012, 2021 & 2027
TABLE 38: China Recent Past, Current & Future Analysis for Vitreous Tamponades by End-Use - Hospitals and Ophthalmology Clinics - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 39: China Historic Review for Vitreous Tamponades by End-Use - Hospitals and Ophthalmology Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 40: China 15-Year Perspective for Vitreous Tamponades by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ophthalmology Clinics for the Years 2012, 2021 & 2027
EUROPE
Vitreous Tamponades Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
TABLE 41: Europe Recent Past, Current & Future Analysis for Vitreous Tamponades by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
TABLE 42: Europe Historic Review for Vitreous Tamponades by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 43: Europe 15-Year Perspective for Vitreous Tamponades by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2021 & 2027
TABLE 44: Europe Recent Past, Current & Future Analysis for Vitreous Tamponades by Product - Gaseous Tamponades and Liquid Tamponades - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 45: Europe Historic Review for Vitreous Tamponades by Product - Gaseous Tamponades and Liquid Tamponades Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 46: Europe 15-Year Perspective for Vitreous Tamponades by Product - Percentage Breakdown of Value Sales for Gaseous Tamponades and Liquid Tamponades for the Years 2012, 2021 & 2027
TABLE 47: Europe Recent Past, Current & Future Analysis for Vitreous Tamponades by End-Use - Hospitals and Ophthalmology Clinics - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 48: Europe Historic Review for Vitreous Tamponades by End-Use - Hospitals and Ophthalmology Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 49: Europe 15-Year Perspective for Vitreous Tamponades by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ophthalmology Clinics for the Years 2012, 2021 & 2027
FRANCE
Vitreous Tamponades Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
TABLE 50: France Recent Past, Current & Future Analysis for Vitreous Tamponades by Product - Gaseous Tamponades and Liquid Tamponades - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 51: France Historic Review for Vitreous Tamponades by Product - Gaseous Tamponades and Liquid Tamponades Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 52: France 15-Year Perspective for Vitreous Tamponades by Product - Percentage Breakdown of Value Sales for Gaseous Tamponades and Liquid Tamponades for the Years 2012, 2021 & 2027
TABLE 53: France Recent Past, Current & Future Analysis for Vitreous Tamponades by End-Use - Hospitals and Ophthalmology Clinics - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 54: France Historic Review for Vitreous Tamponades by End-Use - Hospitals and Ophthalmology Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 55: France 15-Year Perspective for Vitreous Tamponades by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ophthalmology Clinics for the Years 2012, 2021 & 2027
GERMANY
Vitreous Tamponades Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
TABLE 56: Germany Recent Past, Current & Future Analysis for Vitreous Tamponades by Product - Gaseous Tamponades and Liquid Tamponades - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 57: Germany Historic Review for Vitreous Tamponades by Product - Gaseous Tamponades and Liquid Tamponades Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 58: Germany 15-Year Perspective for Vitreous Tamponades by Product - Percentage Breakdown of Value Sales for Gaseous Tamponades and Liquid Tamponades for the Years 2012, 2021 & 2027
TABLE 59: Germany Recent Past, Current & Future Analysis for Vitreous Tamponades by End-Use - Hospitals and Ophthalmology Clinics - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 60: Germany Historic Review for Vitreous Tamponades by End-Use - Hospitals and Ophthalmology Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 61: Germany 15-Year Perspective for Vitreous Tamponades by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ophthalmology Clinics for the Years 2012, 2021 & 2027
ITALY
TABLE 62: Italy Recent Past, Current & Future Analysis for Vitreous Tamponades by Product - Gaseous Tamponades and Liquid Tamponades - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 63: Italy Historic Review for Vitreous Tamponades by Product - Gaseous Tamponades and Liquid Tamponades Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 64: Italy 15-Year Perspective for Vitreous Tamponades by Product - Percentage Breakdown of Value Sales for Gaseous Tamponades and Liquid Tamponades for the Years 2012, 2021 & 2027
TABLE 65: Italy Recent Past, Current & Future Analysis for Vitreous Tamponades by End-Use - Hospitals and Ophthalmology Clinics - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 66: Italy Historic Review for Vitreous Tamponades by End-Use - Hospitals and Ophthalmology Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 67: Italy 15-Year Perspective for Vitreous Tamponades by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ophthalmology Clinics for the Years 2012, 2021 & 2027
UNITED KINGDOM
Vitreous Tamponades Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
TABLE 68: UK Recent Past, Current & Future Analysis for Vitreous Tamponades by Product - Gaseous Tamponades and Liquid Tamponades - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 69: UK Historic Review for Vitreous Tamponades by Product - Gaseous Tamponades and Liquid Tamponades Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 70: UK 15-Year Perspective for Vitreous Tamponades by Product - Percentage Breakdown of Value Sales for Gaseous Tamponades and Liquid Tamponades for the Years 2012, 2021 & 2027
TABLE 71: UK Recent Past, Current & Future Analysis for Vitreous Tamponades by End-Use - Hospitals and Ophthalmology Clinics - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 72: UK Historic Review for Vitreous Tamponades by End-Use - Hospitals and Ophthalmology Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 73: UK 15-Year Perspective for Vitreous Tamponades by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ophthalmology Clinics for the Years 2012, 2021 & 2027
REST OF EUROPE
TABLE 74: Rest of Europe Recent Past, Current & Future Analysis for Vitreous Tamponades by Product - Gaseous Tamponades and Liquid Tamponades - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 75: Rest of Europe Historic Review for Vitreous Tamponades by Product - Gaseous Tamponades and Liquid Tamponades Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 76: Rest of Europe 15-Year Perspective for Vitreous Tamponades by Product - Percentage Breakdown of Value Sales for Gaseous Tamponades and Liquid Tamponades for the Years 2012, 2021 & 2027
TABLE 77: Rest of Europe Recent Past, Current & Future Analysis for Vitreous Tamponades by End-Use - Hospitals and Ophthalmology Clinics - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 78: Rest of Europe Historic Review for Vitreous Tamponades by End-Use - Hospitals and Ophthalmology Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 79: Rest of Europe 15-Year Perspective for Vitreous Tamponades by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ophthalmology Clinics for the Years 2012, 2021 & 2027
ASIA-PACIFIC
Vitreous Tamponades Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
TABLE 80: Asia-Pacific Recent Past, Current & Future Analysis for Vitreous Tamponades by Product - Gaseous Tamponades and Liquid Tamponades - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 81: Asia-Pacific Historic Review for Vitreous Tamponades by Product - Gaseous Tamponades and Liquid Tamponades Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 82: Asia-Pacific 15-Year Perspective for Vitreous Tamponades by Product - Percentage Breakdown of Value Sales for Gaseous Tamponades and Liquid Tamponades for the Years 2012, 2021 & 2027
TABLE 83: Asia-Pacific Recent Past, Current & Future Analysis for Vitreous Tamponades by End-Use - Hospitals and Ophthalmology Clinics - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 84: Asia-Pacific Historic Review for Vitreous Tamponades by End-Use - Hospitals and Ophthalmology Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 85: Asia-Pacific 15-Year Perspective for Vitreous Tamponades by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ophthalmology Clinics for the Years 2012, 2021 & 2027
REST OF WORLD
TABLE 86: Rest of World Recent Past, Current & Future Analysis for Vitreous Tamponades by Product - Gaseous Tamponades and Liquid Tamponades - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 87: Rest of World Historic Review for Vitreous Tamponades by Product - Gaseous Tamponades and Liquid Tamponades Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 88: Rest of World 15-Year Perspective for Vitreous Tamponades by Product - Percentage Breakdown of Value Sales for Gaseous Tamponades and Liquid Tamponades for the Years 2012, 2021 & 2027
TABLE 89: Rest of World Recent Past, Current & Future Analysis for Vitreous Tamponades by End-Use - Hospitals and Ophthalmology Clinics - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 90: Rest of World Historic Review for Vitreous Tamponades by End-Use - Hospitals and Ophthalmology Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 91: Rest of World 15-Year Perspective for Vitreous Tamponades by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ophthalmology Clinics for the Years 2012, 2021 & 2027
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings